OTC drugs Industry Analysis
Here you can find country specific reports on Over-the-Counter Drugs; countries include Europe, UK, USA, Asia and other global markets.
RSS
previous
| OTC Triptans in Kazakhstan (EUR19222) Towards the end of the review period, all triptans remained Rx in Kazakhstan. Euromonitor International's OTC Triptans in Kazakhstan report offers a comprehensive guide to the size and shape of the... | Apr 2013 | £600€711$934 |
| Calming and Sleeping in Kazakhstan (EUR07633) Hectic lifestyles, cumulating personal problems caused by the economic downturn and rising pressure on people, affected sales of calming and sleeping products in 2012. Many Kazakh consumers prefer trying non-prescription... | Apr 2013 | £600€711$934 |
| Calming and Sleeping in Sweden (EUR11803) Calming and sleeping products are increasingly distributed in grocery retailers, other non-grocery retailers and non-store retailing channels. This has helped them to reach and appeal to new consumer segments, which... | Apr 2013 | £600€711$934 |
| OTC Triptans in Azerbaijan (EUR19221) In 2012 all drugs classified as triptans remained Rx in Azerbaijan. Doctors can prescribe triptans to patients suffering from migraines if this diagnosis is approved. Euromonitor International's OTC Triptans in Azerbaijan... | Apr 2013 | £600€711$934 |
| Calming and Sleeping in Azerbaijan (EUR11598) The increasingly stressful lifestyles due to rising urbanisation were an important factor behind growth towards the end of the review period. Increasing incidences of depression on the other side also... | Apr 2013 | £600€711$934 |
| Calming and Sleeping in Chile (EUR10319) Calming and sleeping resumed growth after experiencing a decrease in sales in 2011, when demand dropped after the events that affected Chilean society in 2010 that increased demand of these... | Apr 2013 | £600€711$934 |
| Calming and Sleeping in China (EUR08541) Robust value growth for calming and sleeping products came from the combination of an ageing population and the increasing pursuit of a health lifestyle. Older people who suffer from the... | Apr 2013 | £600€711$934 |
| Calming and Sleeping in Uruguay (EUR07281) Calming and sleeping is where the Ministerio de Salud Pública exerts the tightest controls and imposes the strictest sanctions. The boundary between which calming and sleeping medicines may be bought... | Mar 2013 | £600€711$934 |
| Cough, Cold and Allergy (Hay Fever) Remedies in Uruguay (EUR07195) The sustained good performance of cough remedies and combination products, which were the growth drivers behind the performance of cough, cold and allergy (hay fever) remedies over the review period,... | Mar 2013 | £600€711$934 |
| Calming and Sleeping in Venezuela (EUR07632) Calming and sleeping remained small in size to represent only 1% share of consumer health's value sales in 2012. Factors supporting demand continued since all Venezuelans, no matter their social... | Mar 2013 | £600€711$934 |
| OTC Medications - New Zealand (MIN10817) a snapshot (2012)OTC Medications in New Zealand by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological... | Feb 2013 | £300€355$467 |
| Over-the-counter Pharmaceuticals Market in the Asia Pacific Region (INF02263) 2012-2016TechNavio's analysts forecast the OTC Pharmaceuticals Market in the APAC region to grow at a CAGR of 3.4 percent over the period 2012-2016. One of the key factors contributing to... | Feb 2013 | £1,285€1,522$2,000 |
| OTC Pharmaceuticals (KEY00136) UK Market Report 2013The number of prescriptions distributed across the UK has been increasing rapidly in recent years. Data produced by the Health and Social Care Information Centre (HSCIC) showed that 961.5 million... | Feb 2013 | £395€468$615 |
| Global Over-the-counter Pharmaceutical Market (INF02248) 2012-2016TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 2012-2016. One of the key factors contributing to this market... | Jan 2013 | £1,285€1,522$2,000 |
| The U.S. Market for Rx to OTC Switches (KAL00161) 6th EditionThe U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products, once only available by prescription. This... | Jan 2013 | £2,565€3,038$3,995 |
| The World Outlook for OTC Healthcare Products (ICO06791) 2013-2018This econometric study covers the world outlook for OTC healthcare products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry... | Jan 2013 | £510€604$795 |
| The World Outlook for Over-The-Counter Generic Drugs (ICO06793) 2013-2018This econometric study covers the world outlook for over-the-counter generic drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry... | Jan 2013 | £510€604$795 |
| OTC Medications - Turkey (MIN10743) a snapshot (2012)OTC Medications in Turkey by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies... | Jan 2013 | £300€355$467 |
| OTC Medications - Russia (MIN10616) a snapshot (2012)OTC Medications in Russia by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies... | Jan 2013 | £300€355$467 |
| OTC Medications - US (MIN10623) a snapshot (2012)OTC Medications in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies... | Jan 2013 | £300€355$467 |
| OTC Medications - UK (MIN04350) a snapshot (2012)OTC Medications in UK by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies... | Dec 2012 | £300€355$467 |
| OTC Medications - Portugal (MIN10746) a snapshot (2012)OTC Medications in Portugal by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies... | Dec 2012 | £300€355$467 |
| OTC Medications - Canada (MIN10605) a snapshot (2012)OTC Medications in Canada by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies... | Dec 2012 | £300€355$467 |
| Vitamins & Minerals - China (MIN04097) a snapshot (2012)Vitamins & Minerals in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers single/dual, multi-vitamins and minerals.... | Dec 2012 | £300€355$467 |
| OTC Medications - Netherlands (MIN10614) a snapshot (2012)OTC Medications in Netherlands by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, dermatological remedies... | Dec 2012 | £300€355$467 |
